Interstitial & Diffuse Parenchymal Lung Disease

connective-tissue-disease ILD

Connective-tissue-disease ILD is interstitial lung disease that arises as part of an autoimmune illness, when the immune system that attacks joints, skin, or muscles also turns on the lung. In these conditions the lungs are not an isolated problem but one front of a body-wide disease, and the breathing trouble may be the first or the most serious manifestation.

Several rheumatic diseases are classically involved, including rheumatoid arthritis, systemic sclerosis (scleroderma), polymyositis and dermatomyositis, Sjögren syndrome, and lupus. Systemic sclerosis is a particularly important cause, and in some patients lung involvement dominates the picture and drives the prognosis.

The lung damage can take several CT patterns, but a non-specific interstitial pneumonia pattern with ground-glass and fine reticulation is common, and is generally somewhat more treatable than the UIP pattern. Clues to an autoimmune cause include joint pains, skin or muscle changes, Raynaud's phenomenon, and positive autoantibody blood tests, so the search for these is part of every ILD workup.

Treatment often differs from idiopathic fibrosis, leaning on immune-suppressing drugs to calm the autoimmune process, with antifibrotic therapy added when fibrosis is progressive. Care is usually shared between lung and rheumatology specialists, since controlling the systemic disease and protecting the lungs go hand in hand.

Also called
CTD-ILDCTD-ILDCTD-ILD